Regenxbio RGNX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$193.88M+14.6% | -$227.1M+13.8% | -$263.49M+6.0% | -$280.32M-319% | ||
| $15.62M-3.7% | $16.22M-6.4% | $17.32M+34.2% | $12.91M+35.0% | ||
| $34.56M-10.1% | $38.46M-4.5% | $40.27M-1.3% | $40.79M+5.1% | ||
| -$123.96M+28.4% | -$173.13M+20.7% | -$218.41M-5.3% | -$207.49M-195% | ||
| $2.41M-0.9% | $2.44M-75.5% | $9.96M-67.6% | $30.72M-63.5% | ||
| —— | $103.71M-45.7% | $190.94M— | —— | ||
| —— | —— | -$34.97M-21.2% | -$28.84M— | ||
| —— | —— | -$62.43M+74.9% | -$248.26M-3,418% | ||
| -$126.38M+28.0% | -$175.56M+23.1% | -$228.37M+4.1% | -$238.21M-277% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Regenxbio generate?
- Regenxbio (RGNX) generated -$233.8M in operating cash flow over the trailing twelve months.
- What is Regenxbio's free cash flow?
- After $2.6M of capital expenditures, Regenxbio's free cash flow was -$236.4M over the trailing twelve months, down 171.9% year over year.
- Where does Regenxbio's cash flow data come from?
- Every line is extracted from Regenxbio's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
